Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome

Čierny M, Hooshmand SI, Fee D, Tripathi S, Dsouza NR, La Pean Kirschner A, Zimmermann MT, Brennan R.

Parkinsonism Relat Disord. 2020 Aug;77:110-113. doi: 10.1016/j.parkreldis.2020.06.006. Epub 2020 Jun 25.

Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration

He J, Zhu G, Wang G, Zhang F.

Oxid Med Cell Longev. 2020 Jul 3;2020:6137521. doi: 10.1155/2020/6137521. eCollection 2020.

The class II histone deacetylases as therapeutic targets for Parkinson's disease

Mazzocchi M, Collins LM, Sullivan AM, O'Keeffe GW.

Neuronal Signal. 2020 Jun 9;4(2):NS20200001. doi: 10.1042/NS20200001. eCollection 2020 Jun.

Effects of water-based exercise on functioning and quality of life in people with Parkinson's disease: a systematic review and meta-analysis

Gomes Neto M, Pontes SS, Almeida LO, da Silva CM, da Conceição Sena C, Saquetto MB.

Clin Rehabil. 2020 Dec;34(12):1425-1435. doi: 10.1177/0269215520943660. Epub 2020 Jul 27.

[Insomnia comorbid to Parkinson's disease Part I: Epidemiology, assessment, and related factors]

Lebrun C, Gély-Nargeot MC, Bayard S.

Geriatr Psychol Neuropsychiatr Vieil. 2020 Sep 1;18(3):321-330. doi: 10.1684/pnv.2020.0874.

Management of Orthostatic Hypotension in Parkinson's Disease

Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK.

J Parkinsons Dis. 2020;10(s1):S57-S64. doi: 10.3233/JPD-202036.

Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson's Disease Psychosis

Isaacson SH, Coate B, Norton J, Stankovic S.

J Parkinsons Dis. 2020;10(4):1389-1396. doi: 10.3233/JPD-202047.

Moving Forward in Times of Crisis

Bloem BR, Brundin P.

J Parkinsons Dis. 2020;10(3):747-748. doi: 10.3233/JPD-209001.

Time for a New Image of Parkinson Disease

Armstrong MJ, Okun MS.

JAMA Neurol. 2020 Nov 1;77(11):1345-1346. doi: 10.1001/jamaneurol.2020.2412.

Cognitive and behavioral profile of Perry syndrome in two families

Milanowski Ł, Sitek EJ, Dulski J, Cerquera-Cleves C, Gomez JD, Brockhuis B, Schinwelski M, Kluj-Kozłowska K, Ross OA, Sławek J, Wszolek ZK.

Parkinsonism Relat Disord. 2020 Aug;77:114-120. doi: 10.1016/j.parkreldis.2020.05.019. Epub 2020 Jun 22.

Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease

d'Angelo M, Cimini A, Castelli V.

Int J Mol Sci. 2020 Jul 23;21(15):5241. doi: 10.3390/ijms21155241.

Proteopathic Seed Amplification Assays for Neurodegenerative Disorders

Ferreira NDC, Caughey B.

Clin Lab Med. 2020 Sep;40(3):257-270. doi: 10.1016/j.cll.2020.04.002. Epub 2020 Jun 16.

Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis

Ping F, Jiang N, Li Y.

BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001370. doi: 10.1136/bmjdrc-2020-001370.

Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study

Espinosa-Cárdenas R, Arce-Sillas A, Álvarez-Luquin D, Leyva-Hernández J, Montes-Moratilla E, González-Saavedra I, Boll MC, Garcia-Garcia E, Ángeles-Perea S, Fragoso G, Sciutto E, Adalid-Peralta L.

J Neuroimmunol. 2020 Oct 15;347:577328. doi: 10.1016/j.jneuroim.2020.577328. Epub 2020 Jul 18.

Parkinson's disease and pesticides: Are microRNAs the missing link?

Aloizou AM, Siokas V, Sapouni EM, Sita N, Liampas I, Brotis AG, Rakitskii VN, Burykina TI, Aschner M, Bogdanos DP, Tsatsakis A, Hadjigeorgiou GM, Dardiotis E.

Sci Total Environ. 2020 Nov 20;744:140591. doi: 10.1016/j.scitotenv.2020.140591. Epub 2020 Jun 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias